As A Result Of Its Contribution, What Influence Will Novo Nordisk Have On The Development Of The ATHN Database?

None.  ATHN has received an unrestricted grant from Novo Nordisk.  The agreement explicitly states that Novo Nordisk will not control or otherwise influence the content of the database or information collected by ATHN, nor will they assist in the development of the database or any materials or information disseminated by ATHN.  During the 5 year term of funding, ATHN will acknowledge “Novo Nordisk for supporting the founding and continued support of ATHN through an unrestricted grant.”